These 30 San Francisco/Silicon Valley Health Care Company IPOs had an average stock market price appreciation of an very impressive 72% from their Initial Offering Prices for the very short period of time their common stocks have been trading to their current February 12, 2015 market prices.
Below here are these 30 San Francisco/Silicon Valley Area Health Care IPOs filed so far during the Obama Administration:
% | ||||||||
Market | ||||||||
Price | ||||||||
2-12-15 | Change | |||||||
Stock | Initial | From | ||||||
IPO | San Fran/Silicon Valley Area IPO | City | State | Market | Offering | Offering | ||
Date | During Obama Administration | HQs | Area | Sector | Industry | Price | Price | Price |
$ | $ | |||||||
Health Care IPOs | ||||||||
11/24/10 | Anacor Pharmaceuticals | Palo Alto | SF | Health Care | Biotechnology | 40.83 | 5.00 | 717% |
11/15/13 | Relypsa | Redwood City | SF | Health Care | Biotechnology | 33.38 | 11.00 | 203% |
7/26/12 | Hyperion Therapeutics | Brisbane | SF | Health Care | Biotechnology | 26.88 | 10.00 | 169% |
10/19/11 | ZELTIQ Aesthetics | Pleasanton | SF | Health Care | Medical Appliances& Equipment | 34.20 | 13.00 | 163% |
1/31/14 | Ultragenyx Pharmaceutical | Novato | SF | Health Care | Biotechnology | 53.98 | 21.00 | 157% |
11-6-14 | Nevro | Menlo Park | SF | Health Care | Surgical&Medical Instruments&Apparatus | 43.13 | 18.00 | 140% |
5/22/13 | Portola Pharmaceuticals | South San Francisco | SF | Health Care | Biotechnology | 31.83 | 14.50 | 120% |
7-31-14 | Avalanche Biotechnologies | Menlo Park | SF | Health Care | Biotechnology | 36.28 | 17.00 | 113% |
11-6-14 | Coherus BioSciences | Redwood City | SF | Health Care | Biological Products | 27.82 | 13.50 | 106% |
7-24-14 | Intersect ENT | Menlo Park | SF | Health Care | Sinus Drug Implants | 22.60 | 11.00 | 105% |
9/18/13 | Five Prime Therapeutics | South San Francisco | SF | Health Care | Biotechnology | 24.00 | 13.00 | 85% |
11-14-14 | FibroGen | San Francisco | SF | Health Care | Pharmaceutical Preparations | 29.75 | 18.00 | 65% |
10-16-14 | Atara Biotherapeutics | Brisbane | SF | Health Care | Biological Products | 18.10 | 11.00 | 65% |
10-2-14 | Calithera Biosciences | South San Francisco | SF | Health Care | Pharmaceutical Preparations | 15.49 | 10.00 | 55% |
7/18/13 | OncoMed Pharmaceuticals | Redwood City | SF | Health Care | Biotechnology | 25.76 | 17.00 | 52% |
2/11/11 | AcelRx Pharmaceuticals | Redwood City | SF | Health Care | Medical Appliances & Equipment | 7.35 | 5.00 | 47% |
6-19-14 | Ardelyx | Fremont | SF | Health Care | Biotechnology | 16.43 | 14.00 | 17% |
4-10-14 | Adamus Pharmaceuticals | Emeryville | SF | Health Care | Drugs-Generic | 16.95 | 16.00 | 6% |
10-3-14 | Dermira | Redwood City | SF | Health Care | Pharmaceutical Preparations | 16.63 | 16.00 | 4% |
2/6/14 | Revance Therapeutics | Newark | SF | Health Care | Biotechnology | 16.57 | 16.00 | 4% |
1-30-15 | Avinger | Redwood City | SF | Health Care | Surgical&Medical Instruments&Apparatus | 13.17 | 13.00 | 1% |
1-27-15 | Zosano Pharma | Fremont | SF | Health Care | Pharmaceutical Preparations | 11.01 | 11.00 | 0% |
12/12/13 | Kindred Biosciences | Burlingame | SF | Health Care | Biotechnology | 7.00 | 7.00 | 0% |
3-12-14 | Achaogen | South San Francisco | SF | Health Care | Biotechnology | 11.38 | 12.00 | -5% |
3-21-14 | Versartis | Redwood City | SF | Health Care | Drugs-Generic | 18.59 | 21.00 | -11% |
2/8/12 | ChemoCentryx | Mountain View | SF | Health Care | Biotechnology | 7.81 | 10.00 | -22% |
2-2-11 | Epocrates | San Mateo | SF | Health Care | Info Technology Marketing Services | 11.75 | 16.00 | -27% |
10/30/13 | Veracyte | South San Francisco | SF | Health Care | Biotechnology | 8.55 | 13.00 | -34% |
10/27/10 | Pacific Biosciences of California | Menlo Park | SF | Health Care | Biotechnology | 7.02 | 16.00 | -56% |
11-10-10 | Complete Genomics | Mountain View | SF | Health Care | Physical & Biological Research | 3.15 | 9.00 | -65% |
Average Stock Market Price Increase all 30 Health Care IPOs | 72% |